Literature DB >> 7757265

Evidence for glutamate as neurotransmitter in trigemino-and spinothalamic tract terminals in the nucleus submedius of cats.

A C Ericson1, A Blomqvist, A D Craig, O P Ottersen, J Broman.   

Abstract

The nucleus submedius in the medial thalamus of cats is an important termination site for lamina I trigemino-and spinothalamic tract (TSTT) neurons, many of which are nociceptive-specific, and the nucleus submedius has been proposed to be a dedicated nociceptive substrate involved in the affective aspect of pain. In the present study, the distribution of glutamate was examined by immunocytochemical methods in order to evaluate the possible role of this amino acid as a neurotransmitter in TSTT terminals in the nucleus submedius. TSTT terminals were identified by anterograde transport of horseradish peroxidase and wheatgerm agglutinin-horseradish peroxidase conjugate from the spinal cord or the medullary dorsal horn. Quantitative analysis of immunogold labelling revealed that TSTT terminals contain about twice the tissue average of glutamate-like immunoreactivity. A strong positive correlation was found between the density of synaptic vesicles and the density of gold particles in these terminals, whereas no relationship was seen between these variables in GABAergic presynaptic dendrites. Enrichment of glutamate-like immunoreactivity (approximately 250% of the tissue average) was also observed in terminals of presumed cortical origin. Presynaptic dendrites and neuron cell bodies in the nucleus submedius were found to contain relatively low levels of glutamate-like immunoreactivity, at or below the tissue average. These observations provide evidence that glutamate is a neurotransmitter in lamina I TSTT terminals in the nucleus submedius. The findings also suggest glutamatergic neurotransmission between cortical afferents and nucleus submedius neurons. Glutamate is therefore likely to be an important mediator of nociceptive processing in the medial thalamus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7757265     DOI: 10.1111/j.1460-9568.1995.tb01066.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  7 in total

1.  Organization of AMPA receptor subunits at a glutamate synapse: a quantitative immunogold analysis of hair cell synapses in the rat organ of Corti.

Authors:  A Matsubara; J H Laake; S Davanger; S Usami; O P Ottersen
Journal:  J Neurosci       Date:  1996-07-15       Impact factor: 6.167

2.  Evidence for glutamate as a neurotransmitter in spinothalamic tract terminals in the posterior region of owl monkeys.

Authors:  A Blomqvist; A C Ericson; A D Craig; J Broman
Journal:  Exp Brain Res       Date:  1996-02       Impact factor: 1.972

3.  Contribution of the ventrolateral thalamus to the locomotion-related activity of motor cortex.

Authors:  Irina N Beloozerova; Vladimir Marlinski
Journal:  J Neurophysiol       Date:  2020-08-12       Impact factor: 2.714

4.  Neuronal activity reorganization in motor cortex for successful locomotion after a lesion in the ventrolateral thalamus.

Authors:  Irina N Beloozerova
Journal:  J Neurophysiol       Date:  2021-11-03       Impact factor: 2.714

5.  Synaptic vesicular localization and exocytosis of L-aspartate in excitatory nerve terminals: a quantitative immunogold analysis in rat hippocampus.

Authors:  V Gundersen; F A Chaudhry; J G Bjaalie; F Fonnum; O P Ottersen; J Storm-Mathisen
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

6.  Glutamate, but not aspartate, is enriched in trigeminothalamic tract terminals and associated with their synaptic vesicles in the rat nucleus submedius.

Authors:  Stefan Persson; Jonas Broman
Journal:  Exp Brain Res       Date:  2004-02-17       Impact factor: 1.972

7.  Polyphenolic grape stalk and coffee extracts attenuate spinal cord injury-induced neuropathic pain development in ICR-CD1 female mice.

Authors:  Anna Bagó-Mas; Andrea Korimová; Meritxell Deulofeu; Enrique Verdú; Núria Fiol; Viktorie Svobodová; Petr Dubový; Pere Boadas-Vaello
Journal:  Sci Rep       Date:  2022-09-02       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.